ArticleJournal of personalized medicine2022

A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3.

Christelle de la Fouchardière et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.